Abbott India Financial Statements

Abbott India (ABBOTINDIA) reported revenue of ₹64.09B in FY2025 with net income of ₹14.14B. Total assets stood at ₹59.17B and free cash flow was ₹9.59B.

Abbott India Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		43.91B	49.96B	55.03B	60.97B	64.09B
Cost of Rev. Cost of Revenue		-23.91B	-26.57B	-29.75B	-32.21B	-38.58B
Gross Profit		20.00B	23.39B	25.28B	28.77B	25.51B
SGA Sales, General & Admin		-9.98B	-11.74B	-11.68B	-11.75B	-5.88B
Op. Income Operating Income		9.44B	10.99B	12.90B	16.30B	12.61B
PBT Profit Before Tax		9.26B	10.80B	12.74B	16.18B	18.87B
Net Income		6.91B	7.99B	9.49B	12.01B	14.14B
Dil. Shares Diluted Shares		21.25M	21.25M	21.25M	21.25M	21.25M
Diluted EPS		325.04	375.86	446.78	565.28	665.62

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Abbott India's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Abbott India Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		35.19B	38.53B	30.25B	32.46B	47.65B
Non-curr. assets Total non-current assets		3.22B	3.71B	15.30B	19.48B	11.52B
Total assets		38.40B	42.24B	45.56B	51.93B	59.17B
Curr. liabilities Total current liabilities		10.31B	12.03B	12.06B	13.43B	14.07B
Non-curr. liab. Total non-current liabilities		2.07B	2.01B	1.61B	1.52B	2.77B
Total liabilities		12.38B	14.04B	13.67B	14.95B	16.84B
Total equity		26.02B	28.20B	31.89B	36.99B	42.33B
Total liab. & eq. Total liabilities & equity		38.40B	42.24B	45.56B	51.93B	59.17B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Abbott India's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Abbott India Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		9.26B	10.80B	12.74B	16.18B	18.87B
Operating CF Cash flow Operating Activities		7.27B	9.48B	8.93B	12.13B	10.12B
Capex Investments in PPE		-233.10M	-440.70M	-341.10M	-483.30M	-526.00M
Investing CF Cash flow Investing Activities		-718.20M	-3.96B	-1.48B	-4.16B	1.82B
Dividend Paid		-5.31B	-5.84B	-5.84B	-6.91B	-8.71B
Financing CF Cash flow Financing Activities		-5.82B	-6.37B	-6.39B	-7.45B	-9.25B
Cash (start) Cash at beginning of period		1.45B	2.18B	1.33B	2.40B	2.92B
Cash (end) Cash at end of period		2.18B	1.33B	2.40B	2.92B	5.61B
FCF Free Cash Flow		7.03B	9.04B	8.59B	11.64B	9.59B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Abbott India's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025